Axitinib is a tyrosine kinase inhibitor that blocks the activity of vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3. By inhibiting VEGFR, axitinib reduces the formation of new blood vessels and slows the growth and spread of cancer cells in patients with advanced renal cell carcinoma.

The recommended dose is 5 mg taken orally twice daily, approximately 12 hours apart, with or without food
The tablets should be swallowed whole with water.
Doses may be changed in special conditions so always follow your doctor's or pharmacist's instructions.
If you take more than you should, talk to a doctor or go to the hospital straight away.
If you forget to take a dose, take it as soon as you remember it unless it is nearly time for your next dose.
Do not take a double dose (two doses at the same time) to make up for the forgotten dose.

Like all medicines, this medicine can cause side effects, although not everybody gets them, but you may suffer from:

If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Your doctor will discuss the possible risks and benefits of using this medicine during pregnancy and breast-feeding

Store below 30°C (86°F)
Protect from moisture.
Keep this medicine out of the sight and reach of children.
Store in the original package to protect it from moisture.
Do not use this medicine after the expiry date which is stated on the box/blisters/label. The expiry date refers to the last day of the month.

Inlyta, 5 Mg - 56 Tablets

Overall Product Rating